Email

weborders@prabadincorp.com

Call us

+1 (786)-332-3938

  • Home
  • Blog
  • Latest Post
  • Product Catalog
b77e8639-129a-40c6-b128-527621a55c3a (1)
FDA Approves Ustekinumab-Stba, Biosimilar to Stelara, for Pediatric Patients With PsO or PsA
Health
  • June 16, 2025
By AdminPrabadin - 2 months ago
0

The subcutaneous infusion is indicated for pediatric patients aged 6 to 17 years who weigh less than 60 kg.

Previous article

Keep Looking Up: A Reflection on Our Path Forward

Next article

Nemolizumab Shows Rapid, Sustained Efficacy in Atopic Dermatitis

AdminPrabadin
administrator

Related Articles

Health

Body Fat Percentage Outranks BMI as a Predictor…

  • August 4, 2025
Health

Discontinuing Lenalidomide After ASCT May Be Safe for…

  • August 4, 2025
Health

Hepatitis D Reclassified as Carcinogenic, According to WHO

  • August 4, 2025
© Copyright Barta 2018. Designed and Developed by Komarca Soft